Efficacy and safety of bifidobacterium quadruple viable tablets in the treatment of Helicobacter pylori-infected peptic ulcer or gastritis patients: a systematic review and meta-analysis

Table 2 Types of adverse reactions were analyzed

Adverse reactions	Pooled effect OR, 95%CI	I²,P	Z,P
Loss of appetite	0.57(0.25,1.90)	0.0%,0.839	1.37, P = 0.172
Abdominal distension	0.39(0.16,0.96)	0.0%,0.939	2.05, P = 0.040
Diarrhea	0.30(0.13,0.67)	0.0%,0.526	2.93, P = 0.003
Nausea and vomiting	0.39(0.18,0.82)	0.0%,0.467	2.47, P = 0.014
Nausea	0.37(0.10,1.29)	0.0%,0.891	1.56, P = 0.118
Constipation	0.39(0.19,0.77)	0.0%,0.891	2.68, P = 0.007

ISSN: 1471-2334